These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
287 related articles for article (PubMed ID: 16154838)
1. Hepatic expression of hemochromatosis genes in two mouse strains after phlebotomy and iron overload. Bondi A; Valentino P; Daraio F; Porporato P; Gramaglia E; Carturan S; Gottardi E; Camaschella C; Roetto A Haematologica; 2005 Sep; 90(9):1161-7. PubMed ID: 16154838 [TBL] [Abstract][Full Text] [Related]
2. Hepatic iron metabolism gene expression profiles in HFE associated hereditary hemochromatosis. Gleeson F; Ryan E; Barrett S; Russell J; Crowe J Blood Cells Mol Dis; 2007; 38(1):37-44. PubMed ID: 17098454 [TBL] [Abstract][Full Text] [Related]
3. The mechanisms of systemic iron homeostasis and etiology, diagnosis, and treatment of hereditary hemochromatosis. Kawabata H Int J Hematol; 2018 Jan; 107(1):31-43. PubMed ID: 29134618 [TBL] [Abstract][Full Text] [Related]
4. Relationship between gene expression of duodenal iron transporters and iron stores in hemochromatosis subjects. Nelson JE; Mugford VR; Kilcourse E; Wang RS; Kowdley KV Am J Physiol Gastrointest Liver Physiol; 2010 Jan; 298(1):G57-62. PubMed ID: 19892936 [TBL] [Abstract][Full Text] [Related]
9. Transferrin receptor 2: continued expression in mouse liver in the face of iron overload and in hereditary hemochromatosis. Fleming RE; Migas MC; Holden CC; Waheed A; Britton RS; Tomatsu S; Bacon BR; Sly WS Proc Natl Acad Sci U S A; 2000 Feb; 97(5):2214-9. PubMed ID: 10681454 [TBL] [Abstract][Full Text] [Related]
10. Identification of novel mutations in HFE, HFE2, TfR2, and SLC40A1 genes in Chinese patients affected by hereditary hemochromatosis. Wang Y; Du Y; Liu G; Guo S; Hou B; Jiang X; Han B; Chang Y; Nie G Int J Hematol; 2017 Apr; 105(4):521-525. PubMed ID: 27896572 [TBL] [Abstract][Full Text] [Related]
11. Disruption of hemochromatosis protein and transferrin receptor 2 causes iron-induced liver injury in mice. Delima RD; Chua AC; Tirnitz-Parker JE; Gan EK; Croft KD; Graham RM; Olynyk JK; Trinder D Hepatology; 2012 Aug; 56(2):585-93. PubMed ID: 22383097 [TBL] [Abstract][Full Text] [Related]
12. Combined deletion of Hfe and transferrin receptor 2 in mice leads to marked dysregulation of hepcidin and iron overload. Wallace DF; Summerville L; Crampton EM; Frazer DM; Anderson GJ; Subramaniam VN Hepatology; 2009 Dec; 50(6):1992-2000. PubMed ID: 19824072 [TBL] [Abstract][Full Text] [Related]
13. Iron absorption and hepatic iron uptake are increased in a transferrin receptor 2 (Y245X) mutant mouse model of hemochromatosis type 3. Drake SF; Morgan EH; Herbison CE; Delima R; Graham RM; Chua AC; Leedman PJ; Fleming RE; Bacon BR; Olynyk JK; Trinder D Am J Physiol Gastrointest Liver Physiol; 2007 Jan; 292(1):G323-8. PubMed ID: 16935854 [TBL] [Abstract][Full Text] [Related]
14. Oral Administration of Ginger-Derived Lipid Nanoparticles and Dmt1 siRNA Potentiates the Effect of Dietary Iron Restriction and Mitigates Pre-Existing Iron Overload in Wang X; Zhang M; Woloshun RR; Yu Y; Lee JK; Flores SRL; Merlin D; Collins JF Nutrients; 2021 May; 13(5):. PubMed ID: 34063414 [TBL] [Abstract][Full Text] [Related]
15. Iron overload and prolonged ingestion of iron supplements: clinical features and mutation analysis of hemochromatosis-associated genes in four cases. Barton JC; Lee PL; West C; Bottomley SS Am J Hematol; 2006 Oct; 81(10):760-7. PubMed ID: 16838333 [TBL] [Abstract][Full Text] [Related]
16. Mutations in the HFE, TFR2, and SLC40A1 genes in patients with hemochromatosis. Del-Castillo-Rueda A; Moreno-Carralero MI; Cuadrado-Grande N; Alvarez-Sala-Walther LA; Enríquez-de-Salamanca R; Méndez M; Morán-Jiménez MJ Gene; 2012 Oct; 508(1):15-20. PubMed ID: 22890139 [TBL] [Abstract][Full Text] [Related]
17. Lack of Hfe and TfR2 in Macrophages Impairs Iron Metabolism in the Spleen and the Bone Marrow. Comità S; Falco P; Mezzanotte M; Vujić Spasić M; Roetto A Int J Mol Sci; 2024 Aug; 25(17):. PubMed ID: 39273097 [TBL] [Abstract][Full Text] [Related]
18. Differing impact of the deletion of hemochromatosis-associated molecules HFE and transferrin receptor-2 on the iron phenotype of mice lacking bone morphogenetic protein 6 or hemojuvelin. Latour C; Besson-Fournier C; Meynard D; Silvestri L; Gourbeyre O; Aguilar-Martinez P; Schmidt PJ; Fleming MD; Roth MP; Coppin H Hepatology; 2016 Jan; 63(1):126-37. PubMed ID: 26406355 [TBL] [Abstract][Full Text] [Related]
19. An RNAi therapeutic targeting Tmprss6 decreases iron overload in Hfe(-/-) mice and ameliorates anemia and iron overload in murine β-thalassemia intermedia. Schmidt PJ; Toudjarska I; Sendamarai AK; Racie T; Milstein S; Bettencourt BR; Hettinger J; Bumcrot D; Fleming MD Blood; 2013 Feb; 121(7):1200-8. PubMed ID: 23223430 [TBL] [Abstract][Full Text] [Related]
20. DENND3 p.L708V activating variant is involved in the pathogenesis of hereditary hemochromatosis via the RAB12/TFR2 signaling pathway. Li Y; Xu A; Ouyang Q; Zhang W; Zhang C; Chen Z; Zhou D; Zhang B; Duan W; Zhao X; Wang X; You H; Ou X; Jia J; Huang J Hepatol Int; 2023 Jun; 17(3):648-661. PubMed ID: 36729283 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]